Based on our current findings, we anticipate that fucoxanthin might exhibit great therapeutic efficacy for the treatment of Alzheimer’s disease by acting on multiple targets, including inhibiting AChE and increasing BDNF expression. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.